CHARLOTTE, N.C. – Dentsply Sirona, the world’s leading manufacturer of professional dental products, has appointed Herman V. Cueto as its interim Chief Financial Officer (CFO), effective immediately. Cueto, a highly experienced healthcare executive with over two decades of financial leadership, will take the helm of the company’s financial operations while Dentsply Sirona searches for a permanent CFO.
Cueto joins the company from Azenta Life Sciences, where he served as executive vice president and CFO since October 2023. Azenta specializes in life sciences solutions, particularly in the areas of sample management and genomic services. Prior to his tenure at Azenta, Cueto held significant roles in the finance sector, including senior vice president of finance at Becton, Dickinson and Company (BD), a major medical device manufacturer. At BD, he was responsible for overseeing financial operations across various segments, regions, and business units. Cueto’s career at BD began after its acquisition of C.R. Bard in 2017, where he had spent 14 years in leadership positions, including vice president and group CFO.
Cueto’s wealth of experience in healthcare finance positions him well to steer Dentsply Sirona’s financial strategy during a transitional period. Simon Campion, President and CEO of Dentsply Sirona, expressed confidence in Cueto’s ability to lead, stating, “Herman brings deep financial expertise, operational experience, and a strong understanding of the global healthcare landscape. We are confident that he will keep our finance team focused on executing our strategic goals as we continue the search for a permanent CFO.”
Cueto’s appointment follows the resignation of Glenn Coleman in November 2023, who left to take an executive position with Premier, a healthcare improvement company. Coleman had served as CFO since September 2022, following the departure of Jorge Gomez earlier that year.
Cueto will lead Dentsply Sirona during a period of significant financial and regulatory scrutiny. The company is currently under investigation by German authorities over its intercompany loans, following a 2022 internal review that led to revisions of its 2021 financial statements. Moreover, in October 2024, Dentsply Sirona voluntarily suspended the sales and marketing of its Byte clear aligners and impression kits to reassess regulatory compliance, prompting multiple law firms to investigate potential securities law violations.
Despite these challenges, the company remains focused on its long-term strategic priorities as it works through its ongoing leadership transition.
Related topics:
New Pediatric Dental Clinics Address Critical Gaps in Care for California Children
Renowned Implantology Pioneer Dr. Frank Zastrow Passes Away
